Senescence and serration: a new twist to an old tale

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Oncogene-induced senescence is increasingly recognized for its role in tumorigenesis.
• Cutaneous nevi with Raf-associated senescence exemplify this process in human tumors.
• Malignant transformation of nevi to melanoma involves loss of p16 expression.

Purpose of the Study:

• To explore oncogene-induced senescence in colorectal serrated polyps as a model for tumorigenesis.
• To investigate the distinct pathways initiated by BRAF and KRAS mutations in senescence-associated serrated neoplasia.
• To elucidate the role of methylation in driving tumorigenesis via gene silencing.

Main Methods:

• Comparative analysis of oncogenic pathways in cutaneous nevi and colorectal polyps.
• Investigation of BRAF and KRAS mutation-associated senescence.
• Assessment of CpG island methylator phenotype (CIMP) and microsatellite instability (MSI) status.
• Analysis of gene silencing by methylation in Raf- and Ras-associated pathways.

Main Results:

• BRAF and KRAS mutations initiate distinct senescence-associated serrated neoplasia pathways.
• BRAF-mutant pathway is linked to CIMP-high (CIMP1) and MSI-high status.
• KRAS-mutant pathway is associated with CIMP-low (CIMP2) and MSI-low status.
• Methylation silences pro-apoptotic and cell cycle inhibitory genes, promoting tumorigenesis.
• Both pathways involve mutation of Ras-induced senescence 1 (RIS1).

Conclusions:

• Oncogene-induced senescence is a critical factor in tumorigenesis, observed in both nevi and colorectal polyps.
• Distinct molecular pathways driven by BRAF and KRAS mutations contribute to colorectal cancer development.
• Methylation-mediated gene silencing is a key mechanism in these oncogenic pathways.
• The precise biological role of RIS1 in these processes warrants further investigation.